We work with global life science organisations - empowering them to reach their decarbonisation targets ahead of promised deadlines through our unique 3C approach.
EECO2 is trusted by the world’s largest pharmaceutical companies to design and implement carbon and cost reduction strategies whilst maintaining or improving quality and compliance.
Since 2020, we’ve discovered thousands of carbon optimisation projects across hundreds of pharma sites for a broad range of life science clients – totalling over 160,000 tonnes of CO2 reduction.
We promise to do the same for your organisation.
Learn More About EECO2Click to find out more:
The pharmaceutical industry is responding to the challenge of global warming by reviewing its impact throughout its operations and value chain. In doing this, global life science organisations are setting rapidly approaching decarbonisation targets that will deliver a more sustainable pharma industry within a decade.
Yet the road to net-zero carbon is uncertain. Opportunities to decarbonise are not always obvious, and their wider impact on the business can be hard to understand.
Our extensive experience in net-zero strategy and delivery, identification of optimal decarbonisation and energy reduction opportunities alongside the application of engineering best practice means we are ideally placed to provide guidance and collaboration toward the net-zero future you are striving for.
Find out moreOnce potential projects have been selected from an initial energy assessment, water assessment or ESOS report, we will produce a study that develops a detailed solution. This feasibility study will include concept designs, risk assessments and detailed costs and savings to enable you to fund and implement projects.
Our services in this area include:
Engage with an EECO2 Expert Today
Bring your sustainability questions and we’ll find the answers. We’re always on hand to support your net zero journey, every step of the way.
© Copyright 2023 EECO2
Created by Summit Creative